What is the treatment for epididymitis in men, considering age and underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Epididymitis

Treat epididymitis based on age and sexual activity: men under 35 years require ceftriaxone 250 mg IM once PLUS doxycycline 100 mg orally twice daily for 10 days to cover sexually transmitted organisms (gonorrhea and chlamydia), while men over 35 years need only levofloxacin 500 mg orally once daily for 10 days OR ofloxacin 300 mg orally twice daily for 10 days to target enteric bacteria. 1, 2

Age-Based Treatment Algorithm

Men Under 35 Years (Sexually Active)

  • Primary pathogens: Chlamydia trachomatis and Neisseria gonorrhoeae are the causative organisms in this age group, with chlamydia accounting for two-thirds of cases previously labeled as "idiopathic" 1, 3, 4

  • First-line regimen: Ceftriaxone 250 mg intramuscularly as a single dose PLUS doxycycline 100 mg orally twice daily for 10 days 1, 2, 5

  • Special consideration for men who practice insertive anal intercourse: Use ceftriaxone 250 mg IM once PLUS levofloxacin 500 mg orally once daily for 10 days (or ofloxacin 300 mg orally twice daily for 10 days) to cover enteric organisms like E. coli in addition to sexually transmitted pathogens 1, 2, 3

Men Over 35 Years

  • Primary pathogens: Gram-negative enteric organisms, predominantly Escherichia coli, associated with urinary tract abnormalities, bladder outlet obstruction, or benign prostatic hyperplasia 1, 2, 6, 4

  • First-line regimen: Levofloxacin 500 mg orally once daily for 10 days OR ofloxacin 300 mg orally twice daily for 10 days 1, 2

  • Alternative: Ciprofloxacin 500 mg orally twice daily for 10 days, though rising fluoroquinolone resistance in E. coli is a growing concern 2, 6

Adjunctive Supportive Measures

  • Bed rest with scrotal elevation using a rolled towel or supportive underwear until fever and local inflammation subside 1, 2

  • Analgesics for pain control during the acute inflammatory phase 1, 2

Critical Management Points

Hospitalization Criteria

  • Consider admission when severe pain suggests alternative diagnoses (testicular torsion, testicular infarction, or abscess), when patients are febrile, or when medication compliance is questionable 1

Diagnostic Workup Before Treatment

  • Urethral Gram stain: Look for >5 polymorphonuclear leukocytes per oil immersion field to diagnose urethritis and presumptively identify gonococcal infection 1

  • Nucleic acid amplification testing or culture: Obtain intraurethral swab or first-void urine for N. gonorrhoeae and C. trachomatis 1, 2

  • First-void urine examination: Check for leukocytes if urethral Gram stain is negative; culture this specimen 1

  • Syphilis serology and HIV testing: Recommended for all patients with suspected sexually transmitted epididymitis 1, 2

Follow-Up Requirements

  • Reassess within 3 days: Failure to improve requires reevaluation of both diagnosis and treatment, as testicular torsion may have been missed initially 1, 2

  • Persistent swelling after treatment completion: Comprehensively evaluate for tumor, abscess, infarction, testicular cancer, tuberculosis, or fungal epididymitis 1, 2

Sexual Partner Management

  • Contact tracing: All sexual partners within the preceding 60 days must be evaluated and treated if epididymitis is caused by or suspected to be caused by N. gonorrhoeae or C. trachomatis 1, 2

  • Sexual abstinence: Patients must avoid all sexual intercourse until both they and their partners have completed therapy and are symptom-free 1, 2

  • Partner treatment rationale: Female partners of men with chlamydial epididymitis frequently have cervical chlamydial infection or pelvic inflammatory disease, even when asymptomatic 4

Common Pitfalls and Caveats

Antibiotic Selection Errors

  • Avoid ciprofloxacin monotherapy in men under 35: Ciprofloxacin does not adequately treat urogenital chlamydial infection, which is the predominant pathogen in this age group 7

  • Complete the full 10-day course: Stopping antibiotics early when symptoms improve can lead to treatment failure, chronic pain, and infertility 2, 3

Diagnostic Pitfalls

  • Testicular torsion mimics epididymitis: Sudden onset of severe pain, especially in adolescents or young men without evidence of infection or inflammation, requires emergency surgical consultation because testicular viability is time-dependent 1, 2

  • Urethritis is often asymptomatic: Sexually transmitted epididymitis is usually accompanied by urethritis, but patients may not report urinary symptoms 1

Special Populations

HIV-Infected Patients

  • Same treatment regimen: Uncomplicated epididymitis in HIV-positive patients requires the same antibiotics as HIV-negative patients 1, 2

  • Opportunistic pathogens: Fungi and mycobacteria are more likely causes in immunosuppressed patients and may require alternative diagnostic approaches and treatments 1, 2

Patients with Cephalosporin or Tetracycline Allergies

  • Use fluoroquinolone monotherapy (levofloxacin or ofloxacin) for 10 days, though this may not adequately cover gonorrhea in younger patients 1

Complications of Untreated Disease

  • Infertility: Chlamydial epididymitis is often associated with oligospermia, and untreated infection can lead to permanent reproductive consequences 3, 4

  • Chronic scrotal pain: Inadequate treatment can result in persistent discomfort requiring long-term management 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Epididymitis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epididymitis: An Overview.

American family physician, 2016

Research

Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.